ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere

PHASE2/PHASE3UnknownINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

August 31, 2002

Study Completion Date

December 31, 2005

Conditions
Prostate Cancer
Interventions
DRUG

calcitriol

DRUG

docetaxel

Trial Locations (62)

10032

Columbia Presbyterian Medical Center, New York

10459

Lincoln Medical & Mental Health Center, The Bronx

10960

Union State Bank Cancer Center, Nyack

14263

Roswell Park Cancer Institute, Buffalo

15232

University of Pittsburgh, Pittsburgh

20850

Associates in Oncology Hematology P.C., Rockville

21232

Johns Hopkins University, Baltimore

27511

Raleigh Hematology Oncology Clinic, Cary

29403

Charleston Hematology Oncology, Charleston

29425

Medical University of South Carolina - Hollings Cancer Center, Charleston

30084

Georgia Cancer Specialists, Tucker

30342

Georgia Urology, P.A., Atlanta

33136

University of Miami-Sylvester Comprehensive Cancer Center, Miami

34239

Oncology Hematology Consultants, Sarasota

36106

Montgomery Cancer Center, Montgomery

37403

University Oncology/ Hematology Associates, Chattanooga

38104

Boston Baskin Cancer Group, Memphis

41017

Oncology Hematology Care, Crestview Hills

43222

Mid Ohio Oncology Hematology, Inc., Columbus

44195

The Cleveland Clinic Foundation, Taussig Cancer Center, Cleveland

52807

Urologic Associates- P.C., Davenport

55416

Metro Minnesota CCOP, Saint Louis Park

60077

Midwest Cancer Research Group, Skokie

60153

Loyola University Medical, Maywood

65201

Missouri Cancer Associates, Columbia

68198

Univ. of Nebraska Medical Center/VA Hospital, Omaha

70112

Tulane University Hospital and Clinic, New Orleans

72205

University of Arkansas for Medical Sciences / Central AR VA, Little Rock

75075

North Texas Regional Cancer Center, Plano

75246

Texas Oncology, P.A., Dallas

75702

Tyler Cancer Center, Tyler

76104

Texas Cancer Care, Fort Worth

Urology Associates of North Texas, Fort Worth

78756

Professional Quality Research, Austin

80528

Oncology Hematology Associates, Paudre Calley Cancer Ctr., Fort Collins

85258

Arizona Cancer Center- Scottsdale, Scottsdale

85723

Arizona Cancer Center/Southern Arizona VA HCS, Tucson

85724

Arizona Cancer Center- Tucson, Tucson

87505

New Mexico Cancer Care Associates, Santa Fe

90048

Tower Hematology Oncology Medical Group, Los Angeles

90292

Prostate Oncology Specialist/Pacific Clinical Research, Marina del Rey

92083

San Diego Cancer Center, Vista

92120

Southern California Permanente Medical Group, San Diego

92121

Sharp Healthcare, San Diego

94115

Pacific Hematology Oncology Associates, San Francisco

94589

Kaiser- Northern California, Vallejo

94704

Alta Bates Comprehensive Cancer Center, Berkeley

94904

California Cancer Care, Greenbrae

95817

UC Davis Comprehensive Cancer Center, Sacramento

97201

Oregon Health & Sciences University, Portland

97227

NW Kaiser Permanente Portland, Portland

98109

University of Washington Cancer Care, Seattle

T2N 4N2

Tom Baker Cancer Centre, Calgary

T6G 1Z2

Cross Cancer Institute, Edmonton

V5Z 4E6

Vancouver Cancer Center, Vancouver

R3E OV9

CancerCare Manitoba, Winnipeg

N6A 4L6

London Regional Cancer Centre, London

K1H 1C4

Ottawa Regional Cancer Centre, Ottawa

M4N 3M5

Toronto-Sunnybrook Regional Cancer Center, Toronto

M5G 2M9

Princess Margaret Hospital, University Health Network, Toronto

H2L 4M1

CHUM / Notre-Dame Hospital, Montreal

G1R 2J6

Centre hospitalier universitaire de Quebec, Hotel-Dieu de Quebec, Québec

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Aventis Pharmaceuticals

INDUSTRY

lead

Novacea

INDUSTRY